Cargando…
Metabolites for monitoring symptoms and predicting remission in patients with depression who received electroconvulsive therapy: a pilot study
The lack of biomarkers to monitor and predict the efficacy of electroconvulsive therapy (ECT) has hindered its optimal use. To establish metabolomic markers for monitoring and predicting the treatment efficacy of ECT, we comprehensively evaluated metabolite levels in patients with major depressive d...
Autores principales: | Uchida, Takahito, Sugiura, Yuki, Sugiyama, Eiji, Maeda, Rae, Tanaka, Kenji F., Suematsu, Makoto, Mimura, Masaru, Uchida, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425446/ https://www.ncbi.nlm.nih.gov/pubmed/37580528 http://dx.doi.org/10.1038/s41598-023-40498-7 |
Ejemplares similares
-
Clinical characteristics and potential association to Parkinson’s disease and dementia with Lewy bodies in patients with major depressive disorder who received maintenance electroconvulsive therapy: a retrospective chart review study
por: Kudo, Shun, et al.
Publicado: (2023) -
Impact of Sevoflurane and Thiopental Used Over the Course of Electroconvulsive Therapy: Propensity Score Matching Analysis
por: Yatomi, Taisuke, et al.
Publicado: (2022) -
Remission of treatment-resistant depression with tardive akathisia with electroconvulsive therapy
por: Emmanuel, Thanos
Publicado: (2019) -
Follow-up Study on Electroconvulsive Therapy in Treatment-resistant Depressed Patients after Remission: A Chart Review
por: Tokutsu, Yuki, et al.
Publicado: (2013) -
Remission of Methamphetamine-Induced Withdrawal Delirium and Craving After Electroconvulsive Therapy
por: Ahmadi, Jamshid, et al.
Publicado: (2015)